Response to idebenone and multivitamin therapy in Leber’s hereditary optic neuropathy ALAIAA RESPUESTA, ENNÓ MULTIVITAMINOTERAPIA Arch Soc Esp Oftalmol 82, 377-380, 2007 | 67 | 2007 |
Outcomes of off-label drug uses in hospitals: a multicentric prospective study I Danés, A Agustí, A Vallano, C Alerany, J Martínez, JA Bosch, A Ferrer, ... European journal of clinical pharmacology 70, 1385-1393, 2014 | 39 | 2014 |
Available evidence and outcome of off-label use of rituximab in clinical practice I Danés, A Agustí, A Vallano, J Martínez, C Alerany, A Ferrer, A López, ... European journal of clinical pharmacology 69, 1689-1699, 2013 | 29 | 2013 |
Off-label drug use in hospitals I Danés, C Alerany, A Ferrer, A Vallano Medicina Clínica 143 (7), 327-328, 2013 | 2 | 2013 |
L'homeopatia, ciència o creeça? M Suils, B Oliveras, L Palou, F Farjas, A Ferrer, R Nassarre, L Ramón Perspectiva escolar, 30-34, 2019 | | 2019 |
Off-label drug use in hospitals I Danés, C Alerany, A Ferrer, A Vallano Medicina clinica 143 (7), 327-328, 2014 | | 2014 |
Off-label Use in Five Tertiary Hospitals: Available Evidence and Outcome I Danes, A Agusti, C Valdivia, M Duero, E Ballarin, E Perez, A Vallano, ... Basic & Clinical Pharmacology & Toxicology 113 (Supplement 2), 9-9, 2013 | | 2013 |
Capsulorexis con azul de metileno T Casasín i Edo, A Salvador Payá, M Fossas Real, JC Raitieri Florença, ... Atención farmacéutica 15 (8), 504-505, 1998 | | 1998 |
Capsulorrhexis with methylene blue T Casasin i Edo, A Salvador Playa, M Fossas Real, JC Raitieri Florenca, ... FARMACIA CLINICA 15, 504-505, 1998 | | 1998 |
Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy | | |